| HSE | herpes simplex encephalitis; hemorrhagic shock and encephalopathy |
|---|---|
| Tabs | tablets |
| TAM | tamoxifen; teen-age mother; thermoacidurans agar modified; time-averaged mean; total active motion; ... |
| TMX | tamoxifen |
| HSE | Health and Safety Executive |
|---|---|
| HSE | Heat Shock Elements |
| HSE | Herpes Simplex Encephalitis |
| T | Tamoxifen |
| TAM | Tamoxifen |
| tamoxifen | <drug> An antioestrogen drug that may be given to women with oestrogen receptive tumours to block oestrogen from entering the breast tissues. May produce menopause-like symptoms, including hot flashes and vaginal dryness. Currently being used with high risk women in clinical trials to prevent breast cancer and women who have had breast cancer to prevent recurrence. (14 May 1997) |
|---|---|
| tamoxifen citrate | (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine citrate (1:1);an anti-oestrogen agent used in the treatment of breast cancer. (05 Mar 2000) |
| tamoxifen N-demethylase | <enzyme> Tamoxifen metabolised by cytochrome p-450-dependent mixed function oxidase Registry number: EC 1.5.3.- (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
한서타목시펜정 - 새창
|
한서제약 |
A03602221 | Tamoxifen Citrate | 전문의약품 | 삭제 |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|